First, WME suggested significant association between FGF23 levels and LAS risk with an odds ratio of 1.75 (95% CI 1.06–2.90; p = 0.029), but not with the other IS subtypes or AIS (Supplementary Table 4). This evidence concerns the gene FGF23 and androgen insensitivity syndrome.